FormFactor is breaking out on record fundamentals. It posted three straight revenue records, a run rate above $1B and gross margin above 50% for the first time, and the shares rose 15% on the week. x.com 

ASML's planned 2027-28 output cannot meet customer demand, supporting a Buy rating and €1,830 target. Long-term customer down payments rose from €3.6bn to €9.3bn; customers seek 2029-30 orders that ASML has not accepted. Critical-tool price rises begin in 2027, with full effect in 2028, but are not meant to recur annually. Q3 EPS excluding a €509.7m investment gain still beat consensus. x.com  x.com  x.com  x.com  x.com 

FormFactor is expensive against its earnings, trading at about 38x when chip-equipment makers usually get 18x. Fair value sits at $60.06 to $76.44, or 18x next year's $3.79 EPS give or take 12%, so at $145.97 the price is about 91% above fair. The valuation also leans on the forecast, with forward EPS 177% above trailing. This is a levels-only read off reported earnings and revenue estimates, with no fundamental work. x.com 

FormFactor sits in test and packaging, the best corner of semiconductors this year, where much quiet money is being made in the layer that makes compute functional. It makes the probe cards that test chips and ranks first globally in test subsystems. Last quarter set a revenue record, up 32%, with gross margin up 510 basis points to 49% and EPS beating by 33%. DRAM probe card revenue hit a record on HBM, a product sold out through 2030. x.com 

FormFactor's role as a chip-test supplier to Nvidia underpins the case, and the chart recently formed a double bottom at the 200-day moving average. x.com 

FormFactor's 2030 target model implies either a still-high multiple in 2030 or disappointing share-price gains over the next few years. The model, cited via Citi and apparently management's own, targets $1.6B revenue, 55% gross margin and $5 EPS. The modeled TAM may prove higher, but a margin of safety means assuming today's high multiple won't stay as high. x.com  x.com  x.com  x.com 

Lam Research's record results suggest the equipment cycle is not ending despite its stock selloff. Revenue reached $8.22B, up 54% year over year and over 20% sequentially, while EPS rose 75%; ASML and TSMC also report customers needing more tools. Overweight with a $355 target and 35% upside, but the selloff is a gift only if Lam guides December higher. x.com  x.com 

Accelerating earnings mean ASML is not expensive right now. It trades at 24x forward earnings and 19x forward EV/EBITDA. x.com 

ASML is getting paid more for each tool, moving beyond proving it can build enough of them. Q3 2026 brings pricing power and an order book reaching 2030; the house view has strengthened, with high conviction. x.com 

FormFactor is rated Buy amid the AI sector crash because it is important for HBM, advanced packaging and CPO, where its testing raises yields. Foundry test intensity is only set to increase as production grows. x.com